| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.12 | 7e-05 |